✦ LIBER ✦

Histologic Subtype of Metastatic Renal Cell Carcinoma Predicts Response to Combined Immunochemotherapy with Interleukin 2, Interferon α and 5-Fluorouracil

✍ Scribed by Edwin Herrmann; Olaf Anselm Brinkmann; Marc-Eric Bode; Stefan Bierer; Thomas Köpke; Martin Bögemann; Lothar Hertle; Christian Wülfing

Book ID: 113609704
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 146 KB
Volume: 51
Category: Article
ISSN: 0302-2838
DOI: 10.1016/j.eururo.2006.11.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunochemotherapy with interleukin-2, i

Immunochemotherapy with interleukin-2, interferon- α and 5-fluorouracil for progressive metastatic renal cell carcinoma: a multicenter phase II study

✍ Herpen, C.M.L.v. 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 70 KB

5- fluorouracil blocks T-cell activity d

5- fluorouracil blocks T-cell activity during immunochemotherapy in combination with interferon-alpha and interleukin-2 in metastatic renal cell carcinoma

✍ K. Rohrmann; R. Oberneder; H. Pohla; A. Hofstetter; M. Siebels 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 206 KB

Interleukin-2 with interferon- α 2a and

Interleukin-2 with interferon- α 2a and 5-fluorouracil improves objective response rate compared with tamoxifen in people with metastatic renal cell carcinoma

✍ A. Ravaud 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 93 KB

Phase II trial of 5-fluorouracil, interf

Phase II trial of 5-fluorouracil, interferon-α and continuous infusion interleukin-2 for patients with metastatic renal cell carcinoma

✍ Julie A. Ellerhorst; Avishay Sella; Robert J. Amato; Shi-Ming Tu; Randall E. Mil 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 1 views

## RESULTS. Fifty-five patients were enrolled in the trial and 52 were evaluable for ogy, The University of Texas M. D. Anderson response. All patients experienced fever and flu-like symptoms. Grade 3 or 4 nonhe-Cancer Center, Houston, Texas. matologic toxic effects included hypertension (48%), d

433 5-Fluorouracil blocks lymphocyte act

433 5-Fluorouracil blocks lymphocyte activity during immunochemotherapy with interferon-alpha, interleukin-2 and 5-fluorouracil in metastatic renal cell carcinoma: An in vitro and ex vivo analysis

✍ M. Siebels; K. Rohrmann; H. Pohla; A. Hofstetter 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 217 KB

A Phase II trial of intravenous gemcitab

A Phase II trial of intravenous gemcitabine and 5-fluorouracil with subcutaneous interleukin-2 and interferon-α in patients with metastatic renal cell carcinoma

✍ Christopher W. Ryan; Nicholas J. Vogelzang; Walter M. Stadler 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB 👁 2 views

## Abstract ## BACKGROUND The objective of this study was to determine the response rate and toxicity of gemcitabine and continuous‐infusion 5‐fluorouracil (5‐FU) in combination with subcutaneous interleukin‐2 (IL2) and interferon‐α (IFNA) in patients with metastatic renal cell carcinoma. ## METH